sulfinpyrazone has been researched along with Hyperuricemia in 5 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Hyperuricemia: Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (80.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
GLICK, EN | 1 |
MUGLER, A | 1 |
BERGAMINI, A | 1 |
VENTURA, E | 1 |
SPERBER, RJ | 1 |
FISCH, S | 1 |
DEGRAFF, AC | 1 |
FREUDENTHAL, RR | 1 |
Simon, JA | 1 |
5 other studies available for sulfinpyrazone and Hyperuricemia
Article | Year |
---|---|
Sulphinpyrazone in the treatment of arthritis associated with hyperuricaemia.
Topics: Arthritis; Humans; Hyperuricemia; Phenylbutazone; Sulfinpyrazone; Uric Acid | 1961 |
[Effects of sulfinpyrazone on uricemia and excretion of uric acid in 50 gouty hyperuricemic patients during diuretic thermal treatment. Comparison of its action in simple gout patients and in tophaceous gout patients].
Topics: Biological Transport; Body Fluids; Diuretics; Gout; Humans; Hyperuricemia; Phenylbutazone; Sulfinpyr | 1961 |
[Sulfinpyrazone in juvenile polyarticular gout. Reversible obstructive tubulonephrosis as an early complication of effective uricosuric treatment].
Topics: Gout; Humans; Hyperuricemia; Kidney Diseases; Sulfinpyrazone; Sulfonamides | 1962 |
CORRECTION OF DIURETIC-INDUCED HYPOKALEMIA AND HYPERURICEMIA.
Topics: Bicarbonates; Blood Chemical Analysis; Chlorthalidone; Diuretics; Drug Therapy; Geriatrics; Hydrochl | 1965 |
Clinical trials of uric acid lowering for coronary heart disease risk reduction.
Topics: Clinical Trials as Topic; Coronary Disease; Humans; Hyperuricemia; Myocardial Infarction; Platelet A | 2006 |